BASF Unveils NeoHelix Regenerate, First Precision Peptide for Targeted Collagen Renewal
BASF launched NeoHelix Regenerate, a precision peptide developed with U.S. startup 3Helix that targets damaged collagen for renewal. A 56-day clinical study showed a 41% reduction in damaged collagen and 65% increase in hyaluronic acid levels. BASF also introduced SkinNexus Collag3n, a bio-identical recombinant Collagen III fragment produced via vegan yeast fermentation.